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W. Kimryn Rathmell7,8,9,10, Amir H. Khandani2, Michael E. Woods7,11, 
Matthew I. Milowsky7,8,11, Samira A. Brooks7, Eric. M. Wallen11 & Dinggang Shen2,12
Studies have shown that tumor angiogenesis is an essential process for tumor growth, proliferation 
and metastasis. Also, tumor angiogenesis is an important prognostic factor of clear cell renal cell 
carcinoma (ccRCC), as well as a factor in guiding treatment with antiangiogenic agents. Here, we 
attempted to find the associations between tumor angiogenesis and radiomic imaging features from 
PET/MRI. Specifically, sparse canonical correlation analysis was conducted on 3 feature datasets (i.e., 
radiomic imaging features, tumor microvascular density (MVD), and vascular endothelial growth factor 
(VEGF) expression) from 9 patients with primary ccRCC. In order to overcome the potential bias of 
intratumoral heterogeneity of angiogenesis, this study investigated the relationship between regional 
expressions of angiogenesis and VEGF, and localized radiomic features from different parts within the 
tumors. Our study highlighted the significant strong correlations between radiomic features and MVD, 
and also demonstrated that the spatiotemporal features extracted from DCE-MRI provided stronger 
radiomic correlation to MVD than the textural features extracted from Dixon sequences and FDG PET. 
Furthermore, PET/MRI, which takes advantage of the combined functional and structural information, 
had higher radiomics correlation to MVD than solely utilizing PET or MRI alone.
As much of the focus of personalized oncology has been established on cancer characterization based on genomic 
and proteomic information, tumor definition is derived from invasive biopsy-based molecular assays, typically 
based on a single biopsy assessment. However, assessing the landscape of molecular features has been challenged 
by the issue of intratumoral heterogeneity, as highlighted by the pivotal examination of Gerlinger, et al.1, which 
demonstrated striking genetic heterogeneity in clear cell renal cell carcinoma (ccRCC). Addressing this tumor 
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heterogeneity for appropriate patient assessment and assignment to appropriate therapy has become a crucial 
issue in the field of oncology. As demonstrated and confirmed in the subsequent studies2,3, ccRCCs have extraor-
dinarily spatial and temporal heterogeneity that makes single biopsy limited to reflect the entire tumor genomic 
picture. Radiomics provides a new approach of characterizing and quantifying medical imaging data and adds 
a new dimension for personalization of cancer management4–6. Radiomics builds a high-dimensional mineable 
feature space and also quantitative tumor phenotypes by using automated high-throughput extraction of quan-
titative features of medical images7. And several radiomics-based predictive models have been built for various 
clinical factors (i.e., tumor grades, survival outcomes, treatment response, etc.)7. The opportunity to assess heter-
ogeneous features, beyond the limitations of a single biopsy, and also to re-evaluate these features over time, is an 
essential next step in precision medicine disease evaluations.
Tumor angiogenesis is an essential process for tumor growth, proliferation and metastasis, and is also an 
important prognostic factor of ccRCC and plays a role in guiding treatment8,9. The vascular endothelial growth 
factor (VEGF) and its receptors have been established as key promoters of vascular bed expansion10 and are 
aberrantly expressed in ccRCC. VEGF and VEGFR receptors have been targeted for anti-angiogenesis therapy, 
with several VEGF-targeted agents approved by the FDA to treat metastatic renal cell carcinoma11 These therapies 
can cause both morphologic changes, such as necrosis or hemorrhage, and functional changes, such as reduced 
tumor vascularity, and also cause vasculopathy of medium/large vessels in the treated ccRCCs12,13. However, the 
current method of standard response criteria is based on measurement of tumor diameters, and is limited in 
monitoring the effect of targeted therapy14 Tumor angiogenic activity may be assessed with direct and indirect 
methods, including the commonly used measurement of tumor microvascular density (MVD), which is a den-
sity calculation of vessels in tissue based on immunohistochemical staining of endothelial cells. VEGF is a key 
mitogen that promotes the expansion of vascular networks, and locally corresponds closely with levels of MVD15. 
Compared with the immunohistochemical stains and microarray analysis, which require invasive tissue sampling 
and are difficult to repeat, medical imaging is noninvasive and routinely used in clinical practice. This noninvasive 
method to measure the tumor vascularity could be valuable to monitor the treatment response of targeted ther-
apy agents. Several imaging studies have attempted to find the associations between imaging features and tumor 
angiogenesis, but most of them only focused on temporal-related techniques, such as dynamic contrast enhance-
ment or blood flow imaging, obtained from one single imaging modality16–18. To leverage the emergence of the 
hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) systems, which offers combined 
anatomical details provided by MR imaging and metabolic information from PET, the overarching goal of this 
study is to test the feasibility of measuring microvascular density of ccRCCs by using PET/MRI radiomics. We 
also investigated the added values of PET/MRI by conducting a comparison among spatiotemporal features of 
multiphasic dynamic MRI, additional textural features of Dixon, and glucose metabolic activities of PET.
Methods
Patient Enrollment. This HIPPA-compliant study was reviewed and approved by the institutional review 
board of University of North Carolina. The methods used in this study were carried out in accordance with the 
Declaration of Helsinki. Written informed consent was obtained from each patient prior to study initiation. The 
inclusion and exclusion criteria, protocols of imaging acquisition and tumor specimens processing had been 
published in another previous study19.
Between 2012 and 2013, a total of 18 patients were recruited and imaged, of which 10 patients were histo-
logically confirmed with ccRCC. We used 9 of these 10 patients (5 men; mean age, 55.6 ± 12.5 years) for further 
radiomic analysis in this study, because one patient had suboptimal imaging quality.
PET/MRI Protocol and Region-of-Interest (ROI) Placement. All patients followed a standard-
ized PET/MRI protocol by using a hybrid PET/MRI scanner (Biograph mMR, Siemens Healthcare, Erlangen, 
Germany) as reported in our previous study19. In addition to the standard PET protocol and MR attenuation 
correction sequence, the MRI protocol also included three-dimensional (3D) Dixon sequence and a series of 
breath-hold dynamic contrast enhancement (DCE) sequence using 3D fat-saturated VIBE (volumetric inter-
polated breath-hold examination) at the corticomedullary, nephrographic and excretory phases with delay 
times of 25 s, 75 s, and 180 s, respectively (with the detailed parameters of 3D sequences provided in the 
Supplementary Table S1). In order to investigate the potential links between intratumoral angiogenic expres-
sions and image features, a team of experienced radiologists, nuclear medicine specialists, and surgeons collab-
orated pre-operatively to place several ROIs in different parts of tumors on PET/MRI. Pre-contrast and three 
post-contrast sets of DCE images were then evaluated together. The post-contrast set exhibiting the signal changes 
was finally chosen, overlaid with PET, and visually evaluated. Several ROIs (~1 cm diameter) were defined in the 
regions with FDG uptake, where each defined ROI had internal uniform contrast enhancement. These defined 
ROIs were transferred to the operation room for tissue sampling after total nephrectomy under supervision of 
a board certified radiologist19. Figure 1 shows two illustrative cases of excretory phases of DCE images for ROI 
placement.
Microvascular Density Measurement. Tumor samples were portioned for snap freezing in liquid nitrogen 
or formalin fixed and paraffin embedded. Definiens Tissue Studio software (Munich, Germany) was used to meas-
ure the MVD in the CD31 stained slides. The definition of MVD in this study is the count of Microvessel per unit 
of area rather than the area of Microvessel, as the anti-angiogenic therapy has been shown to exert different influ-
ence between small and medium/large vessels by examining the post-treated tumor specimens12. Therefore, the 
MVD was also divided into small (50–100 μ m2), median (100–1000 μ m2) and large-sized (greater than 1000 μ m2) 
vessels according to the measured sizes. Any vessels with an area less than 50 μ m2 were excluded because CD31 
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can stain more than just vessel endothelium, such as neutrophils, macrophages, platelets, etc. It is difficult to dis-
tinguish microvessel and individual cells or cell fragments that are less than 50 μ m2.
VEGF Analysis. mRNA was extracted from fresh frozen tissue specimens using the Qiagen AllPrep DNA/
RNA Mini Kit (Valencia, CA), amplified, labeled and hybridized against a reference on Agilent Whole Human 
Genome (4 × 44k) Oligo Microarrays, as previously described for all specimens with suitable quality RNA19. The 
expressions of overall VEGF, and members of VEGF family, including VEGF-A, VEGF-B, VEGF-C, and VEGF 
receptor (VEGF-R), were used for the subsequent analyses.
Imaging Realignment and Co-registration. We included four sets of high-resolution 3D images for 
radiomics analysis, including multiphasic dynamic contrast enhancement (DCE), Dixon fat images (Dixon_F), 
Dixon water images (Dixion_W), and 2-[fluorine-18]fluoro-2-deoxy-D-glucose (18F-FDG) PET. PET images 
were converted to standardized uptake value (SUV) maps20–22. In the following section, PET image means the 
SUV map.
Prior to texture analysis, the multimodal intra-subject registrations were conducted. For each subject, PET 
images and MR images, including DCE, DIXON_F and DIXON_W, were aligned to the pre-contrast scout 
Dixon images for structural image registration and motion correction. The FLIRT tool (FMRIB’s Linear Image 
Registration Tool), a fully automated robust and accurate tool, was used for linear (affine) intra- and inter-modal 
image registration, which has been extensively and quantitatively evaluated on many kinds of image modalities 
including PET23–26. In particular, in this study, theo FLIRT tool (FSL v5.0) was used to implement the 3D affine 
registration with 12 parameters. The cost function was the based on the maximization of mutual information, 
and the interpolation was trilinear. Experienced and trained radiologists visually checked the registered images 
in consensus, and confirmed FLIRT to be helpful for structural image registration and motion correction. The 
registration results for subject 1 were shown in Fig. 2, except PET due to limited display space.
Radiomic Features Extraction. A total of 168 radiomic features were extracted automatically by an 
in-house tool implemented in Matlab 2014a (MathWorks Inc.) from MRI, including DCE, Dixon_F, and Dixon_W 
and PET images, which were defined in Supplementary Method and listed in Supplementary Table S227–30. 
These radiomic features described the tumor characteristics and can be divided into two groups: Group 1, spatio-
temporal association features (ST_F); Group 2, texture features (TEX_F). Group 1 included 42 features extracted 
from the time-series modality DCE-MRI, which represented the tumor spatiotemporal enhancement patterns. 
Group 2 consisted of 3 sets of 42 textural features extracted from the non-time-series images (i.e., Dixon_F, 
Dixon_W, and PET) respectively, in which the textural features quantified intra-tumor heterogeneity differences 
in the textures of tumor volume contained within each ROI.
Analysis of Sparse Canonical Correlation. In multivariate analysis, a proper method to inspect the rela-
tionship between two sets of variables based on their correlation is canonical correlation analysis (CCA), which 
determines linear combinations of variables for each data set such that the two linearly combined data sets have 
maximum correlation31. But, CCA usually uses all or most of variables from each data set because its focus is on 
the relationships between variables in different data sets rather than the relationships within each data set, and 
thus hinders the clinical interpretation and biomarker discovery and validation; furthermore, it is not appli-
cable computationally for the case of high dimensional data and small samples, since it is difficult to calculate 
the inverse of covariance matrix of data sets when the number of variables in data sets surpasses the number of 
samples, which is common in radiomic studies. Therefore, in this study, sparse canonical correlation analysis 
Figure 1. Two illustrative cases for selection of ROI location (~1 cm diameter). (a) A ROI was placed in the 
well-enhancing part in left renal clear cell carcinoma in a 37-year-old female patient. The total microvascular 
density was 313.08/mm2. (b) A ROI was placed in left renal cell carcinoma in a 46-year-old female patient. This 
part was only slightly enhanced. The total microvascular density was 54.74/mm2.
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(SCCA)32–34 is performed to overcome the above disadvantage and obtain the correlated sets of variables that 
are sufficiently small for biological interpretation and further investigation. SCCA seeks sparsity in both sets of 
variables simultaneously. It incorporates variable selection and produces linear combinations of small subsets of 
variables from each group of measurements with maximal correlation. The corresponding patterns of non-zero 
coefficients can be interpreted in terms of feature expression that shows similar effects across data sets35.
Suppose that we have M observations of the paired variables ∈x Rp and ∈y Rq. Denote = …X x x x[ , , , ]M
T
1 2  
as the M × p matrix for the first set of variables; and = …Y y y y[ , , , ]M1 2  as the M × q matrix for the second set of 
variables. The SCCA with l1-norm regularization is used to penalize the ordinary CCA by the sum of the absolute 
value of weight vector. We assume that the columns of X and Y have been centered to have zero mean and normal-
ized to have unit variance. The SCCA can then be formulated as a bX Ymax Ta b
T
,  subject to ≤a 12
2 , ≤b 12
2 , 
≤a c1 1, ≤b c1 2.
Where parameters c1 and c2 indicate the sparseness of the projection vectors (or weight vector) a and b, respec-
tively, and adjust the amount of shrinkage. We refer to Xa and Yb as the canonical variables. Since the maximum 
number of canonical variables is =h min p q( , ), the projection matrices are defined as = …a a aA [ , , , ]h1 2 , 
∈ ×A Rp h, and = …b b bB [ , , , ]h1 2 , ∈
×B Rq h, where each column contains the projection vector that is associ-
ated with a canonical variable. The pair of ai and bi is the ith canonical components for X and Y, corresponding to 
the ith largest correlation. The ith largest correlation coefficient between X and Y is computed as 
ρ = a bcor X Y( , )i i i . Here, cor (,) denotes the Pearson correlation function. In this study, Spearman correlation is 
also used, in addition to Pearson correlation, because most other leading studies using radiomics to correlate with 
tumor phenotype have demonstrated that imaging features tend to have a nonparametric relationship with bio-
logical parameters36–38.
To identify the latent pairwise relationships among the radiomic features, microvascular density and VEGF, 
we constructed three data set matrices: (1) RF for radiomic features; (2) MVD for microvascular density; (3) 
VEGFset. A row of RF consists of 168 dimensions, involve 42 dimensional ST_F and 126 dimensional TEX_F. 
MVD matrix include 4 features, i.e., total MVD, and MVD of small-sized, middle-sized, large-sized vessels 
respectively. VEGFset contains 5 variables, VEGF, VEGF-A, VEGF-B, VEGF-C and VEGR-R. So, there are 2 pairs 
of relationships to be analyzed. (1) RF and MVD, where we obtain four pairs of canonical weight vectors, each 
pair of which have a canonical correlation coefficient. (2) RF and VEGFset, where we obtain 5 pairs of canonical 
weight vectors and also 5 corresponding correlation coefficients.
Figure 2. The multimodal intra-subject registered results of subject 1 except PET. There are 6 red boxes, 
which are divided into 2 rows and 3 columns. Each box is obtained from ITK-SNAP, and composed of 4 sub-
figures: top left sub-figure is about axial plane, top right sub-figure about sagittal plane, bottom right about 
coronal plane. In the top row, the left box is about DCE time 1 (pre-enhanced), the middle one is about DCE 
time 2 (postenhanced), the right one about DCE time 3 (postenhanced); in the bottom row, the left box is about 
DCE time 4 (postenhanced), the middle one about Dixon_F, and the right one about Dixon_w.
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Identifying PET/MRIFeatures Associated with Angiogenesis. In order to compare the contributions 
of different sets of imaging features, we grouped the features into 4 sets to simulate possible clinical situations: 
DCE alone (only using features of DCE images), MRI alone (combined DCE features and Dixon features), PET 
alone (only using features of FDG PET), and PET/MRI (combined all features), where we performed the SCCA 
analysis respectively.
Results
The mean tumor size was 8.2 ± 4.8 cm (ranging 3.5–17 cm) and the median Fuhrman grade was 2 (ranging 2–4). 
The median clinical AJCC staging was 2 (ranging 1–4). In total, 43 tumor samples were collected from the 9 
ccRCC tumors, with a range of 3–6 subsamples taken from each tumor. MVD were successfully obtained from 
all specimens (159 ± 94.7/mm2), and expressions of VEGF family and VEGFR were obtained from 23 of the 
specimens.
Radiomic Analysis. We performed pairwise relationships of sparse canonical correlation analysis between 
radiomics features, MVD and VEGFset.
Sparse Canonical Correlation Analysis between RF and MVD. Figures 3–12 show the results of the 
canonical correlation analysis, which demonstrate the relationship (i.e., linear combination of weights) among 
three sets of variables, including radiomic features, MVD, and VEGF family. The height of each bar shows the 
correlation of each variable with the corresponding set of canonical weights. The canonical correlation coefficient 
(ρ) for each pair of linear composites is shown in the legends of each pair, representing the relationship between 
the two sets of variable (radiomic features vs. MVD, or radiomic features vs. VEGF family).
Microvessel 
density
PET/MRI DCE alone MRI alone (DCE + Dixon) PET alone
Pearson 
correlation
Spearman 
Correlation
Pearson 
correlation
Spearman 
Correlation
Pearson 
correlation
Spearman 
Correlation
Pearson 
correlation
Spearman 
Correlation
Whole 0.639257121 0.466324373 0.538858721 0.340984597 0.531014484 0.347780127 0.43974722 0.440652371
small 0.634724358 0.375415282 0.542388517 0.365297493 0.532341511 0.366807611 0.42893314 0.367411658
middle 0.626200618 0.512836001 0.501232994 0.306704923 0.492377955 0.315010571 0.441627902 0.455451525
large 0.608610984 0.655693144 0.452889697 0.255964965 0.527560997 0.327393537 0.282646961 0.298701299
p value (Z-stat) 0.044 0.048 0.084 0.26
Table 1.  Correlation coefficients of microvascular density of different vessel sizes (in rows) and sets of 
radiomic features selected for sparse canonical correlation analysis (in column).
Figure 3. The first canonical component for sparse canonical correlation analysis between microvascular 
density and radiomic features (p = 0.044 for z-stat) with spearman correlation coefficient ρ1 = 0.466. 
Figure 4. The second canonical component for sparse canonical correlation analysis between 
microvascular density and radiomic features (p = 0.044 for z-stat) with spearman correlation coefficient 
ρ2 = 0.375. 
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Based on the above descriptions, it is known that h = 4 pairs of canonical components can be extracted. As 
shown in Figs 3–6, with significance level of p = 0.044, there are 4 clear and explicable relationships between 
MVD and RF with 43 specimens, which correlation coefficient are in Table 1 with the canonical components of 
total MVD, small-sized, medium-sized, and large-sized MVD, respectively.
In Figs 3–6, it can be observed that the effects of DCE, Dixon_F and PET of RF dominate all four pairs of 
canonical components. The 1st, 13rd, 25th and 31st features (i.e., PE.Mean, WiS.Mean, TE_PE.Mean and TE_WiS.
Mean in DCE) are the most consistent dominant weight vectors of RF in all canonical components. Other dom-
inant features include the 74th feature (i.e., GLSZM.SZLGE in Dixon_F) in total MVD, MVD of small-sized and 
medium-sized MVD, the 127th feature (i.e., GLOBAL.Variance in PET), in small-sized, medium-sized MVD, 
and the 53rd feature (i.e., GLCM.Variance in Dixon_F), the 102nd feature (i.e., GLRLM.HGRE in Dixon_W), and 
the 151st feature (i.e., GLSZM.SZE in PET) in large-sized MVD. The heap map in Fig. 7 shows the association 
of the radiomic feature expression and angiogenesis, which are from the 1st pair of canonical components. The 
columns represent specimens, and the rows represent the radiomic features with their loadings not equal to zero 
in canonical component.
Identifying PET/MRI Features Associated with Angiogenesis. In Table 1, we have summarized the 
results of SCCA using different group of features. Only groups of features extracted from DCE and PET/MRI 
achieved significant correlations between radiomic features and MVD. There were no significant correlations 
between MVD and the features from MRI or PET alone.
The correlation coefficients are the highest in the PET/MRI group, which incorporate both radiomic features 
from PET and MRI, than DCE alone, MRI alone and PET alone.
Sparse Canonical Correlation Analysis between RF and VEGF set with 23 Specimens. There are 
at most h = 5 pairs of canonical components that can be extracted. As shown in Figs 8–12, there are 5 relation-
ships between RF and VEGF set. However, the relationships are not significant (p = 0.169 for z-stat).
Although the results were not significant, it is noticeable that the temporal features of DCE are not the most 
contributing features to all of the VEGF family. There are different trends of contributions of imaging features to 
each component of VEGF family. Total VEGF expressions were associated with features of DCE, Dixon_F and 
PET images. VEGF-A expressions, which is the main component of VEGF family and stimulates angiogenesis in 
health and diseases11, were more associated with Dixon_F and PET images. The effects of VEGF-B on patholog-
ical angiogenesis were less pronounced, and the deficiency of VEGF-B in mice does not impair angiogenesis in 
normal development39. In our study, VEGF-B expressions were more associated with RF of Dixon_W, which is 
different from the patterns of other members of VEGF family. One of the receptors of VEGF-C, VEGF-R3, is cru-
cial for formation of the blood vasculature during early embryogenesis, and also important in later formation of 
new lymphatic vessels40. VEGF-C expressions were associated with both Dixon_F and Dixon_W, and expressions 
of VEGF receptor were most associated with Dixon_F and PET images.
Figure 5. The 3rd canonical component for sparse canonical correlation analysis between microvascular 
density and radiomic features (p = 0.044 for z-stat) with spearman correlation coefficient ρ3 = 0.513. 
Figure 6. The 4th canonical component for sparse canonical correlation analysis between microvascular 
density and radiomic features (p = 0.044 for z-stat) with spearman correlation coefficient ρ4 = 0.656. 
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Discussion
One of the major advantages of this study was that the pathological tissue sections, from which MVD and expres-
sions of VEGF family were measured, were all carefully extracted from the pre-defined ROIs, which provides 
an opportunity to perform region-to-region histological correlations of abstract radiomics features. Our results 
demonstrated several findings. First, we successfully identified the significant correlations between radiomic fea-
tures and MVD. Second, spatiotemporal features extracted from DCE provide the highest loadings for expla-
nation of the radiomic correlations of MVD than textural features from Dixon sequences and FDG PET. Third, 
taking advantage of the combined functional and structural information of FDG PET and MRI, this study has 
shown higher radiomics correlation of MVD than solely utilizing PET or MRI alone.
The four most consistently dominant features (loading > 0.3) correlated with MVD were all spatiotemporal 
features of DCE about rapid gadolinium uptake, including absolute and relative peak enhancement and also 
wash-in slopes after gadolinium enhancement, which are similar with previous parameters described in breast, 
liver and colorectal cancers41–47. Although early tumor washout, probably associated with leaky capillaries, has 
Figure 7. Heat map showing the association of the radiomic feature expression and angiogenesis, which are 
from the 1st pair of canonical component. The columns represent specimens which are sorted from right to left 
according to the Microvessel density, and rows represent the radiomic features which loadings are not equal to 
zero in canonical component, and are from up to down in descending order according to the absolute value.
Figure 8. The 1st canonical component for sparse canonical correlation analysis between radiomic features 
and VEGF (p = 0.169, z-stat) with spearman correlation coefficient ρ1 = 0.756. 
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also been proposed to be correlated with MVD, we were not able to find such significant associations between 
washout slope features and MVD.
The advantages of PET/MRI include shorter acquisition time of PET and MR images, which can increase 
the toleration of participants, and also simultaneous acquisition minimizes the chances of interscan motion and 
inevitable variation of tumor conditions. The ccRCC is characteristic of intracytoplasmic lipid accumulation. In 
this study, in addition to spatiotemporal features from DCE, we also extracted additional features from the Dixon 
sequence, which can separate the fat and water components of tumors and has been proposed to differentiate 
benign and malignant renal tumor using signal intensity drop in chemical-shift MRI48. As shown in Table 1, com-
pared with using DCE images alone, additional features of Dixon contributed to a small improvement of corre-
lation. As to glucose metabolism, ccRCCs utilize aerobic glycolysis in a similar way of ATP production like many 
other cancers, which are reflected by increased uptake on 18F-FDG PET49. Although our results showed the PET 
features had no significant correlations with MVD, compared with DCE-MRI features, a combined dual-modality 
features of PET/MRI achieved the highest performance of radiomic correlations with MVD.
VEGF is thought to play a major role in tumor angiogenesis. Although a decrease in permeability parameter, 
Ktrans, has been described in DCE-MRI parameters after administration of anti-VEGFR agents50, no studies, uti-
lizing imaging for assessing the vascular features of renal tumors, had identified significant correlations between 
VEGF expressions and kinetic CT or MRI parameters16,51. Our second part of the radiomic analysis also did not 
identify significant associations between imaging features and VEGF family expressions. On the other hand, 
we observed a significant association with MVD, which represents an important functional metric of VEGF 
signaling in renal tumors. The potential value of the ability to assess tumors spatially with regard to functional 
features like MVD is 1) providing potential additional prognostic information, 2) adding information that may 
be valuable in predicting a diagnosis of disease that is either benign or indolent vs. malignant and with metastatic 
potential, and 3) guiding biopsy or surgical planning. This opportunity, in an era of rapid expansion in precision 
treatment selection, provides a potentially highly valuable piece of information, particularly in the selection of 
therapy that is likely to include anti-angiogenic agents. Finally, the evaluation of disease state for systemic therapy 
planning will allow physicians to assess disease holistically, rather than from just the end of a single needle. But, 
further studies with a large sample size are certainly necessary to investigate the trends we observed, and also the 
integration studies in which anti-angiogenic agents are administered will be an important future consideration.
There are several limitations in this study. First, in 47% of the samples (20/43), there were insufficient spec-
imens for measurement of VEGF expressions, which may be insufficient to assess the associations of radiomic 
features. Further investigation on more cases may improve the statistical power. Second, the temporal resolution 
of multiphasic imaging is lower than the 5-second or 6-second temporal resolution in other DCE studies, which 
can more precisely determine the wash-in and wash-out parameters18,52. Higher temporal resolution will likely 
improve the utility of spatiotemporal features. Third, in order to improve the accuracy of image registration, 
we only utilized Dixon and DCE images, which provide 3D highresolution isotropic images, but we did not 
include other commonly-used 2D sequences, including T2-weighted MRI and diffusion-weighted MRI, which 
have thicker slices and are thus sensitive to patient motion between slices.
Figure 9. The 2nd canonical component for sparse canonical correlation analysis between radiomic features 
and VEGF (p = 0.169, z-stat) with spearman correlation coefficient ρ2 = 0.603. 
Figure 10. The 3rd canonical component for sparse canonical correlation analysis between radiomic 
features and VEGF (p = 0.169, z-stat) with spearman correlation coefficient ρ3 = 0.674. 
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In summary, our analysis is a step forward towards highlighting the clinical advantage of hybrid PET/MRI and 
radiomics-based clinical interpretation. This study has utilized radiomics analysis to correlate with angiogene-
sis of primary ccRCCs using PET/MRI. Our results suggested that PET/MRI radiomic features, including peak 
enhancement and wash-in slope, might be able to quantify MVD in primary ccRCC. The results, obtained in this 
study, are just the basis to predict intratumor genomic heterogeneity in the future. In learning (classification or 
regression) models, the learning accuracy and training speed may be significantly deteriorated by those superflu-
ous features. So, it is of fundamental importance to select the relevant and necessary features in the preprocessing 
step53. A good feature subset is one that contains features highly correlated with the class yet uncorrelated with 
each other54. In this sense, SCCA is a good method for feature selection because SCCA seek a sparse solution of 
CCA by incorporating variable selections to cope with the multi-collinearity within each dataset, and maximize 
the mutual information between the two datasets55,56. But our conclusions are limited by the small size of samples 
used. With expanding radiomics cohort and feature dimensions, we expect higher correlation in the future radi-
omics studies. Also, further investigation is needed to validate our findings on a larger cohort of data. Through 
our presented workflow, we also hope to extend the application of radiomics analysis to predicting intratumor 
genomic heterogeneity in the future.
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